"As a result of the growing scrutiny of PBMs by regulators, litigation involving PBMs has only increased.... [It] is important for plans to be aware of their fiduciary obligations under ERISA as it relates to their pharmacy programs. [This article provides] concrete steps plan sponsors and plan administrators can take now that can curtail any resulting liability arising from this litigation or any subsequent actions that follow."  MORE >>